Nucleic acid aptamers as tools and drugs: recent developments.
about
Identification of a 14mer RNA that recognizes and binds flavin mononucleotide with high affinity.Aptamer antagonists of myelin-derived inhibitors promote axon growthDeconvolution of a complex target using DNA aptamers.An antiproliferative genetic screening identifies a peptide aptamer that targets calcineurin and up-regulates its activity.Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology.Crystallization and preliminary X-ray diffraction data of an LNA 7-mer duplex derived from a ricin aptamer.Rapid detection of natriuretic peptides by a microfluidic LabChip analyzer with DNA aptamers: Application of natriuretic peptide detection.DNA aptamer evolved by cell-SELEX for recognition of prostate cancer.Emulsion PCR: a high efficient way of PCR amplification of random DNA libraries in aptamer selection.Solution structure of an informationally complex high-affinity RNA aptamer to GTPA mathematical analysis of the selective enrichment of NECEEM-based non-SELEX.A novel aptamer developed for breast cancer cell internalizationComparative crystallization and preliminary X-ray diffraction studies of locked nucleic acid and RNA stems of a tenascin C-binding aptamer.VEGF/VEGFR signalling as a target for inhibiting angiogenesis.RNA as a versatile and powerful platform for engineering genetic regulatory tools.Therapeutic applications of aptamers.The chemical biology of aptamers.Application of locked nucleic acids to improve aptamer in vivo stability and targeting functionApplications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases.Enzymatic recognition of 2'-modified ribonucleoside 5'-triphosphates: towards the evolution of versatile aptamers.Use of RNA in drug design.Characterisation of aptamers for therapeutic studies.Regulatory RNAs: charming gene management styles for synthetic biology applications.The design of RNA binders: targeting the HIV replication cycle as a case study.Fluorescence assay based on aptamer-quantum dot binding to Bacillus thuringiensis spores.Beyond antibodies: new affinity reagents to unlock the proteome.Pattern recognition of enrichment levels of SELEX-based candidate aptamers for human C-reactive protein.In vitro detection of human breast cancer cells (SK-BR3) using herceptin-conjugated liquid crystal microdroplets as a sensing platform.A comparative analysis of perturbations caused by a gene knock-out, a dominant negative allele, and a set of peptide aptamers.Aptamers and Their Significant Role in Cancer Therapy and Diagnosis.Aptamers: novelty tools for cancer biology.Methods To Identify Aptamers against Cell Surface BiomarkersDetermination of Enrofloxacin in Bovine Milk by a Novel Single-Stranded DNA Aptamer Chemiluminescent Enzyme ImmunoassayLocked Nucleic Acid Oligonucleotides toward Clinical Applications
P2860
Q25255133-5895F268-06AE-473B-82B3-761A663818EDQ28473221-FD20BF9D-2265-46CC-9DC5-7F63859E7FCDQ33221136-44B493A9-0D63-4E15-BEDE-9574367921D0Q33265421-1040051B-64BE-4022-97B1-B01592E20833Q33492343-3C05A1F0-FEEB-463F-AB77-3B1B86AD4585Q33499182-433011A1-9471-491C-8776-D48DD3108D99Q33714038-DB66C684-E5F9-45A0-9F1F-D89B03B7D9CAQ33793416-E1CB2098-42E0-4D8F-AE2A-24EB910BABFEQ34031592-CF732FF1-004E-4A20-9E74-8AFECA310F54Q34498130-9BAB50E1-9080-4590-8812-A0855109E2BFQ35173981-D2166512-89C6-43C3-8A57-EBA78066A51DQ36124893-43FF8067-054D-4787-87BB-BC7B0EFCDA4FQ36459520-13403C3D-8FBB-430E-B56F-2036FE841AB2Q36677407-EE244A4D-9AEB-474D-991D-9E510BEF49F5Q37024725-E3ED38E8-82A4-4CB0-B3FD-BD7707666A1BQ37038988-04353595-FECA-433A-B1FF-EEA2DE91B0CDQ37423243-1FD8A247-EBE9-4F84-932B-BA4D41BCFECEQ37619467-8400AA6C-3C39-407A-B3DD-0225684FB686Q37815481-277216EB-8AEB-43C9-BAF6-DA64CA8119F2Q37967636-5FC5CA34-0965-463C-AF6C-5709FDC636DAQ38089160-F8C6272C-5912-4AF8-A196-94B15CA28671Q38089865-C5B8930B-5845-4CCA-9C37-91BE7B7FBB0CQ38172811-03E88AEB-5574-4732-AC8C-93A402535308Q38237585-6AC1C087-0CFD-4BC3-B5EB-E05F4949C9A0Q38305225-A586C89C-910B-41EE-951F-23CAAB495D12Q38309923-3005761E-34E6-4218-A3FC-070A77E94ECAQ47986452-0D71B630-985E-406A-81E0-299841817573Q51196083-0E18C5DF-A249-455B-B25F-A9559ABA34FAQ53530479-F1663E9B-41FA-471A-9B3E-8E3AE2DA9553Q54457076-20990D12-CC41-4B16-89AB-384313A2BCCFQ55285633-29933C2D-FF95-4F10-B8F6-25427AC3734FQ57018191-015359F1-DD98-4373-B29F-127DEA8C5A5AQ58129071-53D3A404-9927-40E0-91C1-AACA571D0E98Q59004652-D89CC555-0931-4892-B3BC-52D4676224EC
P2860
Nucleic acid aptamers as tools and drugs: recent developments.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Nucleic acid aptamers as tools and drugs: recent developments.
@ast
Nucleic acid aptamers as tools and drugs: recent developments.
@en
type
label
Nucleic acid aptamers as tools and drugs: recent developments.
@ast
Nucleic acid aptamers as tools and drugs: recent developments.
@en
prefLabel
Nucleic acid aptamers as tools and drugs: recent developments.
@ast
Nucleic acid aptamers as tools and drugs: recent developments.
@en
P2860
P356
P1433
P1476
Nucleic acid aptamers as tools and drugs: recent developments.
@en
P2093
Martina Rimmele
P2860
P304
P356
10.1002/CBIC.200300648
P577
2003-10-01T00:00:00Z